Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Northfield Closes Blood Replacer Plant

by Michael McCoy
May 18, 2009 | A version of this story appeared in Volume 87, Issue 20

Northfield Laboratories is closing its plant in Mount Prospect, Ill., and laying off its entire staff there, effectively ending its effort to develop a red blood cell substitute. Late last month, the company received a letter from FDA stating that the agency would not approve the product, a chemically modified hemoglobin called PolyHeme. Northfield is one of several firms trying to develop blood substitutes (C&EN, Feb. 23, page 52).

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.